Public Alert No.027/2021- Statins: Drug Safety Communication – US Food And Drug Administration (FDA) Requests Removal Of Strongest Warning Against Using Cholesterol-Lowering Statins During Pregnancy
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by the U.S FDA about revisions to the prescribing information of the entire class of statin medicines, regarding their use in pregnancy. These changes include removing the contraindication against using these medicines in all pregnant patients. A contraindication is FDA’s […]
